{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:26:49Z","timestamp":1773098809505,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Malignant pleural mesothelioma (MPM) is a lethal disease with scarce therapeutic options, and preclinical studies\non new targeted-agents are warranted. Because previous studies reported high c-Met expression and alterations in the\nmicrotubules network in most MPM samples, we evaluated the activity of tivantinib, which has been recently suggested to\naffect microtubule polymerization in addition to inhibiting c-Met. In four MPM cell lines tivantinib inhibited both c-Met\nactivity and microtubule polymerization, resulting in inhibition of cell-growth with IC&lt;sub&gt;50&lt;\/sub&gt;s ranging between 0.3 &amp;#181;M\n(MSTO-211H) and 2.4 &amp;#181;M (H2052). Furthermore tivantinib synergistically enhanced the antiproliferative and proapoptotic\nactivity of pemetrexed, as detected by sulforhodamine-B-assay and flow cytometry. The synergistic interaction\nwas associated with reduction of thymidylate synthase expression and inhibition of migratory activity. In aggregate, these\ndata show the ability of tivantinib to specifically target key pathways in MPM cells and synergistically interact with pemetrexed,\nsupporting further studies on this therapeutic approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389450116666141205160924","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T14:40:14Z","timestamp":1418654414000},"page":"1331-1340","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells"],"prefix":"10.2174","volume":"15","author":[{"given":"Leticia G.","family":"Leon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gemelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Sciarrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Avan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccola","family":"Funel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research of the Canary Islands, Instituto de Tecnologias Biomedicas, University of La Laguna, Campus de la Salud s\/n, 38071 La Laguna, Tenerife, Spain.,Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450116666141205160924","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/126773\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450116666141205160924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:52:00Z","timestamp":1761389520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/126773\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":0,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450116666141205160924","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2014-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}